187 related articles for article (PubMed ID: 12225554)
1. Intravenous prostacyclin combined with inhaled nitric oxide therapy for an infant with alveolar capillary dysplasia.
Kinugasa H; Horigome H; Sugiura M; Saito T; Iijima T; Matsui A
Pediatr Int; 2002 Oct; 44(5):525-7. PubMed ID: 12225554
[No Abstract] [Full Text] [Related]
2. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide.
Kelly LK; Porta NF; Goodman DM; Carroll CL; Steinhorn RH
J Pediatr; 2002 Dec; 141(6):830-2. PubMed ID: 12461501
[TBL] [Abstract][Full Text] [Related]
3. Intravenous prostacyclin in the treatment of persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide.
Golzand E; Bar-Oz B; Arad I
Isr Med Assoc J; 2005 Jun; 7(6):408-9. PubMed ID: 15984391
[No Abstract] [Full Text] [Related]
4. Use of inhaled nitric oxide for the treatment of persistent pulmonary hypertension of the newborn (PPHN).
Robinson T; Stewart DL; Hilbert T
J Ky Med Assoc; 1999 Mar; 97(3):100-4. PubMed ID: 10189770
[No Abstract] [Full Text] [Related]
5. Inhaled nitric oxide and inhaled prostacyclin in acute respiratory distress syndrome: what is the evidence?
Puri N; Dellinger RP
Crit Care Clin; 2011 Jul; 27(3):561-87. PubMed ID: 21742217
[TBL] [Abstract][Full Text] [Related]
6. Persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide and prostacyclin, responsive to neuromuscular blockade.
Filippi L; Serafini L; Gozzini E; Poggi C; Moroni M; Fiorini P
Minerva Pediatr; 2011 Jun; 63(3):233-5. PubMed ID: 21654603
[TBL] [Abstract][Full Text] [Related]
7. Intravenous prostacyclin mitigates inhaled nitric oxide rebound effect: A case control study.
Hermon M; Golej J; Burda G; Marx M; Trittenwein G; Pollak A
Artif Organs; 1999 Nov; 23(11):975-8. PubMed ID: 10564300
[TBL] [Abstract][Full Text] [Related]
8. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.
Tibballs J; Goh TH; McKenzie I; Hochmann M
Anaesth Intensive Care; 1999 Jun; 27(3):316-7. PubMed ID: 10389572
[No Abstract] [Full Text] [Related]
9. Combined therapy with inhaled nitric oxide and intravenous prostacyclin in an infant with alveolar-capillary dysplasia.
Parker TA; Ivy DD; Kinsella JP; Torielli F; Ruyle SZ; Thilo EH; Abman SH
Am J Respir Crit Care Med; 1997 Feb; 155(2):743-6. PubMed ID: 9032222
[TBL] [Abstract][Full Text] [Related]
10. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
11. Long survival of congenital alveolar capillary dysplasia patient with NO inhalation and epoprostenol: effect of sildenafil, beraprost and bosentan.
Kodama Y; Tao K; Ishida F; Kawakami T; Tsuchiya K; Ishida K; Takemura T; Nakazawa A; Matsuoka K; Yoda H
Pediatr Int; 2012 Dec; 54(6):923-6. PubMed ID: 23279022
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide in the management of persistent pulmonary hypertension of the newborn--an unusual cause of failure.
Jerwood DC; Stokes MA
Paediatr Anaesth; 1995; 5(3):193-5. PubMed ID: 7489441
[TBL] [Abstract][Full Text] [Related]
13. Current and future therapeutic options for persistent pulmonary hypertension in the newborn.
Rao S; Bartle D; Patole S
Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):845-62. PubMed ID: 20528642
[TBL] [Abstract][Full Text] [Related]
14. The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol.
Ramsay MA; Spikes C; East CA; Lynch K; Hein HA; Ramsay KJ; Klintmalm GB
Anesthesiology; 1999 Jan; 90(1):299-301. PubMed ID: 9915339
[No Abstract] [Full Text] [Related]
15. Outcome in term infants treated with inhaled nitric oxide.
Rosenberg AA
J Pediatr; 2002 Mar; 140(3):284-7. PubMed ID: 11953722
[No Abstract] [Full Text] [Related]
16. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
17. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.
Barry PW
Anaesth Intensive Care; 1999 Dec; 27(6):670-1. PubMed ID: 10631434
[No Abstract] [Full Text] [Related]
18. Treatment of pulmonary arterial hypertension.
Humbert M; Sitbon O; Simonneau G
N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
[No Abstract] [Full Text] [Related]
19. Nitric oxide, oxygen, and prostacyclin in children with pulmonary hypertension.
Turanlahti MI; Laitinen PO; Sarna SJ; Pesonen E
Heart; 1998 Feb; 79(2):169-74. PubMed ID: 9538311
[TBL] [Abstract][Full Text] [Related]
20. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
